VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 200 filers reported holding VAXCYTE INC in Q4 2022. The put-call ratio across all filers is 0.72 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $991 | +2.8% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $964 | +33.5% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $722 | -23.4% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $943 | -99.7% | 20,000 | +48.1% | 0.00% | +100.0% |
| Q3 2022 | $328,000 | +18.4% | 13,500 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $277,000 | -14.8% | 13,500 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $325,000 | +9.8% | 13,500 | +9.8% | 0.00% | 0.0% |
| Q4 2021 | $296,000 | -5.7% | 12,300 | +2.5% | 0.00% | 0.0% |
| Q3 2021 | $314,000 | +16.7% | 12,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $269,000 | +20.6% | 12,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $223,000 | -33.2% | 12,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $334,000 | – | 12,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 4,168,718 | $99,174,000 | 24.03% |
| Medicxi Ventures Management (Jersey) Ltd | 1,887,478 | $44,903,000 | 11.24% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,111,485 | $26,442,000 | 11.06% |
| FRAZIER MANAGEMENT LLC | 2,309,554 | $54,944,000 | 4.23% |
| Kynam Capital Management, LP | 211,483 | $5,031,000 | 2.69% |
| GREAT POINT PARTNERS LLC | 500,000 | $11,895,000 | 2.64% |
| Ghost Tree Capital, LLC | 250,000 | $5,948,000 | 2.13% |
| RA Capital Management | 4,240,464 | $100,881,000 | 1.78% |
| Opaleye Management Inc. | 315,800 | $7,513,000 | 1.59% |
| Ikarian Capital, LLC | 295,111 | $7,021,000 | 1.05% |